Lydia Hanaa Faris

• Nozawa K, Terada M, Onishi M, Ozaki Y, Takano T, Fakhouri W, Novick D, Haro JM, Faris LH, Kawaguchi T, Tanizawa Y and Tsurutani J Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR +, HER2-metastatic breast cancer patients in Japan Breast Cancer 2023. 30(4): 657-665.
• Faris LH, Gabarrell A, Félez M, Cristobal P, Mortier P, Vilagut G, Olaya B, Alonso J, Haro JM, López-Carrilero R and Domènech J The Association Between Substance Use Disorder and Depression During the COVID-19 Lockdown in Spain and the Moderating Role of Social Support: a Cross-Sectional Study. International Journal of Mental Health and Addiction 2023. 21(2): 1-11.

Project name:

INTEGRATE-LMedC_Concept development for a research infrastructure to manage, integrate and sustain large medical cohort studies

Leader

Josep Maria Haro Abad

Funding entities:

European Commission

Code

101131809

Starting - finishing date:

2024 - 2026

Project name:

IMPROVA - e-Intervention Enhancing Mental Health in Adolescents

Leader

Josep Maria Haro Abad

Funding entities:

European Commission, Fundació Privada per a la Recerca i la Docència Sant Joan de Déu - FSJD, Antunes Lima, Rodrigo

Code

10108093

Starting - finishing date:

2023 - 2027

Project name:

RESPOND_Improving the Preparedness of Health Systems to Reduce Mental Health and Psychosocial Concerns resulting from the COVID-19 Pandemic

Leader

Josep Maria Haro Abad

Funding entities:

European Commission

Code

101016127

Starting - finishing date:

2020 - 2024